Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The hellenic experience
Marina P. Siakantaris(National and Kapodistrian University of Athens), John Dervenoulas(National and Kapodistrian University of Athens), Ioanna Sakellari(G. Papanikolaou General Hospital), Panagiotis Tsirigotis, Αchilles Anagnostopoulos(G. Papanikolaou General Hospital), Evangelia Papadavid(National and Kapodistrian University of Athens), Niki Stavroyianni(G. Papanikolaou General Hospital), Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), Christina Antoniou(Peter MacCallum Cancer Centre), Vasiliki Pappa(Children's Hospital of Philadelphia), Konstantinos Girkas(National and Kapodistrian University of Athens), Spiros Chondropoulos(National and Kapodistrian University of Athens)
Cited by 12
Related Papers
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
|New England Journal of Medicine|2015|937
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
|European Journal of Cancer|2017|449
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
|Journal of Clinical Oncology|2015|419
The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients
|British Journal of Dermatology|2018|235